Ulta Beauty | Report on maternal health benefits at Ulta Beauty

Status
Withdrawn
AGM date
Resolution details
Resolution ask
Report on or disclose
ESG theme
  • Social
ESG sub-theme
  • Public health
Type of vote
Shareholder proposal
Filer type
Shareholder
Company sector
Consumer Discretionary
Company HQ country
United States
Resolved clause
RESOLVED: In order to limit the impact of the maternal mortality crisis on its workforce, shareholders request that Ulta Beauty report on any specialized current health services and support provided for pregnant and postpartum employees, and assess the feasibility of establishing and expanding additional maternal support for employees. The report should be prepared at reasonable cost, omitting proprietary information and shall be completed by September 1, 2024.
Whereas clause
WHEREAS: In the United States, women are dying from pregnancy and birth complications at a shocking rate. The US has the highest maternal death rate of any developed country.1 In 2019, the maternal mortality rate was 20.1 deaths per 100,000 live births in the United States. In 2020, the maternal death rate increased to 23.8.2 Importantly, Black women are disproportionately affected, as maternal mortality rates are almost three times higher for Black women than for non-Hispanic white women and Hispanic women. Employee pregnancy and birth complications are a higher risk for Ulta than many other companies, as its 36,000-strong workforce is overwhelmingly female. 94% of Ulta’s total U.S. workforce are female, 8% of its U.S. management are Black, and 11% of its U.S. nonmanagement workforce are Black. Ulta can take action to reduce the risk of pregnancy and birth complications for its employees. The CDC found that two-thirds of pregnancy related deaths between 2008 and 2017 were preventable.3 Healthcare services and support can dramatically reduce negative pregnancy outcomes.4 Health measures and other services to support pregnant and postpartum employees can include breastfeeding support, contraception, doula and midwifery services, preconception care such as folic acid, gestational diabetes screening and treatment, perinatal depression screening and treatment, preeclampsia screening and treatment, Rh incompatibility screening and treatment, childcare support and/or stipends, paid parental leave, and access to abortion services, among other measures. It is unclear from public disclosures whether Ulta’s insurance benefits currently provide any of these support services for pregnant employees. Proactively supporting pregnant and postpartum employees would benefit Ulta by enhancing employee health, encouraging retention, attracting new talent, and lowering healthcare costs for employees and the Company

DISCLAIMER: By including a shareholder resolution or management proposal in this database, neither the PRI nor the sponsor of the resolution or proposal is seeking authority to act as proxy for any shareholder; shareholders should vote their proxies in accordance with their own policies and requirements.

Any voting recommendations set forth in the descriptions of the resolutions and management proposals included in this database are made by the sponsors of those resolutions and proposals, and do not represent the views of the PRI.

Information on the shareholder resolutions, management proposals and votes in this database have been obtained from sources that are believed to be reliable, but the PRI does not represent that it is accurate, complete, or up-to-date, including information relating to resolutions and management proposals, other signatories’ vote pre-declarations (including voting rationales), or the current status of a resolution or proposal. You should consult companies’ proxy statements for complete information on all matters to be voted on at a meeting.